Alison Turner

3.0k total citations · 1 hit paper
33 papers, 2.0k citations indexed

About

Alison Turner is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Alison Turner has authored 33 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Alison Turner's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Virus-based gene therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Alison Turner is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Virus-based gene therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Alison Turner collaborates with scholars based in United Kingdom, United States and New Zealand. Alison Turner's co-authors include Adrian V. S. Hill, Simon J. Draper, Sumi Biswas, Andrew R. Williams, Carole A. Long, Kazutoyo Miura, Kevin Marsh, Joseph J. Illingworth, Gathoni Kamuyu and Gavin J. Wright and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Alison Turner

33 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

2013 833 citations Andrew R. Williams, Sumi Biswas et al. Nature Communications profile →

Peers

Countries citing papers authored by Alison Turner

Since Specialization

Citations

This map shows the geographic impact of Alison Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Turner more than expected).

Fields of papers citing papers by Alison Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Turner. The network helps show where Alison Turner may publish in the future.

Co-authorship network of co-authors of Alison Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Turner. A scholar is included among the top collaborators of Alison Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Turner. Alison Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune response to COVID ‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response 2022 ·British Journal of Haematology ·Karthik Ramasamy, Ross Sadler, (unknown), (unknown), (unknown), Alison Turner, (unknown), Nathanael S. Gray, (unknown), (unknown), Stella Bowcock, Udo Oppermann, Gordon Cook, Chara Kyriakou, Mark T. Drayson, Supratik Basu, Sally Moore, Sarah McDonald, Sarah Gooding, M K Javaid	14
2	On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation 2021 ·Communications Biology ·(unknown), (unknown), Tania F. Rowley, Robert Oldham, Sonya James, (unknown), Ruth R. French, Alison Turner, Stephen A. Beers, David P. Humphreys, Mark S. Cragg	17
3	A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF 2021 ·Nature Communications ·Daniel Lightwood, (unknown), John Porter, David McMillan, Bruce Carrington, Alison Turner, Anthony Scott-Tucker, (unknown), Antje Schmidt, David Fox, Alison Maloney, Tom Ceska, Tim Bourne, James P. O’Connell, Alastair D. G. Lawson	22
4	Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma 2018 ·American Journal of Respiratory and Critical Care Medicine ·Daniel Lightwood, (unknown), (unknown), Kaushik Sarkar, Alison Turner, Marguerite Bracher, Bryan Smith, (unknown), Tim Bourne, Stevan Shaw, Neil Gozzard, Roger Palframan	24
5	Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector 2017 ·Methods in molecular biology ·Vincent Pavot, Sarah Sebastian, Alison Turner, (unknown), Sarah C. Gilbert	16
6	Laboratory-Scale Production of Replication-Deficient Adenovirus Vectored Vaccines 2015 ·Methods in molecular biology ·Susan Morris, Alison Turner, Nicola Green, George M. Warimwe	4
7	Immunisation against a serine protease inhibitor reduces intensity of Plasmodium berghei infection in mosquitoes 2013 ·International Journal for Parasitology ·Andrew R. Williams, Sara E. Zakutansky, Kazutoyo Miura, Matthew D. J. Dicks, Thomas S. Churcher, (unknown), Aisling Vaughan, Alison Turner, Melissa C. Kapulu, Kristin Michel, Carole A. Long, Robert E. Sinden, Adrian V. S. Hill, Simon J. Draper, Sumi Biswas	15
8	Towards a universal vaccine for avian influenza: Protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus 2012 ·Vaccine ·Amy Boyd, (unknown), Marylène Péroval, Connor Carson, (unknown), Karen Staines, Alison Turner, Adrian V. S. Hill, Sarah C. Gilbert, Colin Butter	42
9	The Discovery, Engineering and Characterisation of a Highly Potent Anti-Human IL-13 Fab Fragment Designed for Administration by Inhalation 2012 ·Journal of Molecular Biology ·Daniel Lightwood, Victoria O’Dowd, Bruce Carrington, Václav Veverka, Mark D. Carr, (unknown), Alistair J. Henry, Bryan Smith, Kerry Tyson, (unknown), Kaushik Sarkar, Alison Turner, Alastair D. G. Lawson, Tim Bourne, Neil Gozzard, Roger Palframan	30
10	Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors 2011 ·Biotechnology and Bioengineering ·Matthew G. Cottingham, (unknown), Susan Morris, Alison Turner, Aisling Vaughan, Melissa C. Kapulu, Stefano Colloca, Loredana Siani, Sarah C. Gilbert, Adrian V. S. Hill	35
11	Defining the directionality and quality of influenza virus–specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virus 2008 ·Journal of Clinical Investigation ·Victoria Kasprowicz, Scott M. Ward, Alison Turner, Alexandros Grammatikos, Brian E. Nolan, Lia Laura Lewis‐Ximenez, Charles Sharp, (unknown), Vicki M. Fleming, Stuart Sims, Bruce D. Walker, Andrew K. Sewell, Georg M. Lauer, Paul Klenerman	37
12	Detailing the Novel Structure of the Biopharmaceutical Certolizumab Pegol 2008 ·The American Journal of Gastroenterology ·Bryan John Smith, T.A. Ceska, (unknown), (unknown), Alison Turner, Sam Heywood, John O’Hara, Andrew Nesbitt	3
13	Effect of PEGylation on the Solution Conformation of Antibody Fragments 2007 ·Journal of Pharmaceutical Sciences ·Yanling Lü, Stephen E. Harding, Alison Turner, Bryan Smith, D. S. Athwal, J. Günter Grossmann, Kenneth G. Davis, Arthur J. Rowe	48
14	A New Self-Assembling System for Targeted Gene Delivery 2000 ·Angewandte Chemie ·Michael A. W. Eaton, (unknown), Catherine Catterall, (unknown), (unknown), Barbara Mason, Timothy J. Norman, David Parker, Justin J. Perry, Richard J. K. Taylor, Alison Turner, A. Neil C. Weir	16
15	Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM) 1996 ·British Journal of Cancer ·Pari Antoniw, (unknown), Alison Turner, (unknown), Angela Mountain, J. Mackintosh, (unknown), John L. Humm, (unknown), (unknown), (unknown), DJ King	26
16	Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice 1994 ·British Journal of Cancer ·Alison Turner, DJ King, (unknown), (unknown), RB Pedley, (unknown), R Boden, (unknown), Kenneth Millar, Byron A. Boyce, (unknown), (unknown), David Parker	9
17	A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody 1993 ·Molecular Immunology ·Sarojani Angal, David J. King, Mark Bodmer, Alison Turner, (unknown), Gerald D. Roberts, R. Barbara Pedley, John R. Adair	187
18	The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates 1991 ·International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·A. Harrison, (unknown), David Parker, Karl J. Jankowski, J. P. Cox, Andrew S. Craig, J. M. Sansom, Nigel R. A. Beeley, Rich Boyce, L Chaplin, Michael A. W. Eaton, (unknown), Kenneth Millar, Andrew T. Millican, (unknown), (unknown), (unknown), Alison Turner	62
19	Detection of Antibodies in Human Sera to the Repeating Epitope of the Circumsporozoite Protein of Plasmodium falciparum Using the Synthetic Peptide (NANP)3 in an Enzyme-Linked Immunosorbent Assay (ELISA) 1987 ·American Journal of Tropical Medicine and Hygiene ·Gary H. Campbell, A. David Brandling-Bennett, Jacquelin M. Roberts, F. H. Collins, Dan Kaseje, Ann Barber, Alison Turner	23
20	Biomechanical and Clinical Assessment of Hip Nerve Block in Unilateral Osteoarthrosis 1982 ·Engineering in Medicine ·Daniel Bader, (unknown), Alison Turner, J. Edmonds‐Seal, David J. Fuller	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact